Further considerations for venom immunotherapy following the withdrawal of Pharmalgen.
Michel Erlewyn-LajeunesseCherry AlvianiStephanie CrossEmma Grainger-AllenPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2020)
Keyphrases